Life Sciences Alternative Funding - Web3 Crypto Company Profile, Funding, Valuation, Investors - Cointime

Bitcoin $96,124.47 -0.92%
Ethereum $3,348.47 -1.35%
BNB $672.44 +0.64%
Optimism $1.81 -0.04%
Arbitrum $0.77 +0.25%
Solana $185.40 -0.60%
Polygon $0.48 -1.04%
Cosmos $6.56 -1.62%
Avalanche $37.30 -2.38%

Bitcoin $96,124.47 -0.92%
Ethereum $3,348.47 -1.35%
BNB $672.44 +0.64%
Optimism $1.81 -0.04%
Arbitrum $0.77 +0.25%
Solana $185.40 -0.60%
Polygon $0.48 -1.04%
Cosmos $6.56 -1.62%
Avalanche $37.30 -2.38%

Life Sciences Alternative Funding

investment firm

Summary
Investments
Exits
Employees

About

Life Sciences Alternative Funding provides capital to commercial-stage life sciences companies.

White Plains,New York,United States
http://www.lsafunding.com

Highlights

Lead Investments

Employee Profiles

Details

Operating Status: Active
Investor Type: Venture Debt

Investments

Number of Investments

Number of Lead Investments

4

1

Life Sciences Alternative Funding has made 4 investments. Their most recent investment was on May 12, 2015, when Harrow Health raised $15M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
May 12, 2015 Harrow Health	Post-IPO Debt	$15M	Biotechnology	—
Mar 10, 2015 Veniti	Debt Financing	—	Biotechnology	Yes
Apr 29, 2014 Integrated Diagnostics	Debt Financing	$17M	Biotechnology	—
Sep 17, 2013 VisionCare Ophthalmic Technologies	Debt Financing	$15M	Health Care	—

Employee Profiles

Number of Employee Profiles

1

Life Sciences Alternative Funding has 1 current employee profiles, including Executive Steve DeNelsky

Executive

Exits

Life Sciences Alternative Funding has had 3 exits. Life Sciences Alternative Funding most notable exits include Veniti , Integrated Diagnostics

Date	Company Name	Exit Type	Industry
Aug 8, 2018	Veniti	M&A	Biotechnology	Detail
Jul 9, 2018	Integrated Diagnostics	M&A	Biotechnology	Detail
Apr 30, 2007	Harrow Health	IPO	Biotechnology	Detail